Streamlining Your External Network of CMOs to Ensure Product Quality and Compliance

It’s hardly surprising that pharma companies are changing the way they work with external partners, with increasing pressures on quality, cost and scalability determining not only which manufacturers the industry outsources to, but how many partners to take on.

With this in mind, Pharma IQ spoke with Simon Hendry, BD Director, Adare Pharmaceuticals, on the current challenges and best practices of streamlining external networks of CMOs. Hendry, speaks in-depth on the critical success factors you need to uncover in the selection process and how to manage emerging markets, all whilst ensuring quality isn’t compromised.

Download the full interview on the right >>

Other key benefits to downloading the full interview:

• Analysing what changes need to be made over the next 12-24 months to meet the main challenges of the industry
• Understanding the best practices for building a successful CMO partnership
• Exploring what criteria is most valuable to the industry when selecting a CDMO